中国 Wuhan Desheng Biochemical Technology Co., Ltd 企業ニュース

In the golden September, Yangcheng gathers. From September 26th to 29th, 2025, the global healthcare industry will once again focus on Guangzhou, welcoming the grand opening of the 92nd China International Medical Equipment Fair (CMEF). As an innovative force in the field of core raw materials for in vitro diagnostics (IVD), Hubei Xindesheng Materials Technology Co., Ltd. is ready to go. Led by the company's general manager, an elite team consisting of technical elites and domestic and foreign sales backbones set off from Hubei on September 25th to attend this top-level industry event (booth number: C06 in Hall 20.1), aiming to present a precise diagnostic technology feast to global customers with a series of innovative enzyme preparations and mature core products. 1, Innovation engine: New enzyme preparations make a heavyweight debut, empowering precise diagnosis in new dimensions At this year's CMEF, Xindesheng will launch a new generation of high-purity and highly stable enzyme preparation series that it has carefully developed, including key indicator detection materials such as lactate dehydrogenase (LDH), uricase (UO), creatine kinase isoenzyme (CK-MB), etc. These new products are not only a concentrated reflection of the company's research and development capabilities, but also directly address the higher demand for detection sensitivity, specificity, and inter batch stability in the current IVD testing market. These new enzyme preparations have injected strong power into Xindesheng's "innovation engine", indicating that the company has taken a more solid step on the road of independent research and development of key raw materials, aiming to help downstream reagent manufacturers enhance their product core competitiveness. 2, Stable cornerstone: Core product matrix appears together, showcasing the full chain supply strength While showcasing its innovative edge, Xindesheng will also showcase its traditional core product matrix that has been validated in the market for a long time, demonstrating its comprehensive strength as a reliable supplier. Biological buffering agents, such as Tris, HEPES, Bicine, etc., have excellent purity and provide a stable reaction environment for diagnostic reagents. Chemiluminescent reagents, including luminol and acridine ester luminescent reagents, have the advantages of high luminescence efficiency and sensitive reaction. Chromogenic substrates such as TOOS, TOPS, MAOS, MADB, etc. are sensitive and stable for color development, and are suitable for various enzyme immunoassay analyses. Blood collection tube additives: a full range of products including serum separation gel, anticoagulant, coagulant, silicification agent, etc., provide support for front-end sample processing. New Desheng's product line covers multiple key aspects of IVD reagent development and production, including reaction environment construction, signal generation, and sample preprocessing, demonstrating its strong ability to provide customers with a "one-stop" raw material solution. 3, Face to face communication: Elite teams gather to discuss new chapters of cooperation In this exhibition, Xindesheng not only sent out products, but also a powerful "think tank" and "service team". The general manager, technical experts, and domestic and foreign sales elites gather together to have zero distance and in-depth communication with customers and partners from around the world. Whether it's exploring cutting-edge technology trends, analyzing specific project requirements, or negotiating customized services and international market cooperation, the New Desheng team is fully prepared and looks forward to colliding ideas and listening to market voices on the open platform of CMEF. With more flexible and thoughtful services, we will explore the infinite possibilities of diagnostic technology development together with industry colleagues. Conclusion: At the right time for the grand event, Xindesheng is waiting for your visit in Guangzhou! The exhibition has now grandly opened, and excitement is unfolding! The booth of Hubei Xindesheng is ready, and our team is eagerly awaiting the visit of all new and old friends in Guangzhou with full enthusiasm. Now, by visiting the New Desheng booth (booth number: C06, Hall 20.1), you will be able to: Personally observe and understand the appearance and excellent performance of new enzyme preparations and core products; Face to face with the general manager and technical experts to deeply discuss your customized needs and technical challenges; Obtain the latest product information and cooperation policies. The opportunity is rare, and the grand event is in full swing! We look forward to meeting you in Yangcheng, seeking common development and a win-win future!

On September 19, 2025, the golden autumn brings a refreshing feeling and the fragrance of osmanthus flowers fills the air. In this beautiful season of harvest and hope, we warmly welcome our important strategic partner from afar - Ms. Anu Moturi, founder of Kriya Medical Technologies (KriyaMed), an Indian blood collection industry enterprise. This visit is a deep interaction between the two sides after embarking on a journey of cooperation, aimed at reviewing the fruitful cooperation process and jointly drawing up a grand blueprint for future development. During the visit, both parties held talks on the in-depth cooperation and future market strategy of EDTA K3 and separation gel, and conducted on-site inspections of our new Huanggang factory. Both sides walked together, sharing their cooperative friendship and seeking common development plans, creating a warm and harmonious atmosphere on site. Under the leadership of founder Anu Moturi, KriyaMed has become an undeniable force in the Indian blood collection tube market. Since establishing a partnership with our company 6-7 years ago, both parties have supported each other and grown together. Ms. Anu Moturi's personal visit this time not only reflects her appreciation for the long-term cooperative relationship with our company, but also demonstrates her firm determination to further deepen cooperation and jointly explore the market. At the beginning of the visit, our company's Chairman Mr. Wang Zhongxi, General Manager Ms. Wang Anqi and other senior leaders expressed their warmest welcome to Ms. Anu Moturi's visit. During the cordial and friendly talks, both sides jointly reviewed the achievements of their cooperation over the past five years. Ms. Anu Moturi expressed her sincere gratitude to our company for providing stable and high-quality product supply, as well as timely and professional technical services. She clearly stated that one of the core objectives of this visit is to explore with our company a more competitive cooperation price for EDTA K3 anticoagulant and core raw material separation gel based on a larger procurement scale in the future, in order to further enhance the competitiveness of KriyaMed products in the Indian market. More notably, Ms. Anu Moturi confidently shared KriyaMed's next strategic development plan. She announced that the company has set clear goals to significantly increase the production capacity and market share of separation gel blood collection tubes, striving to become the leader in the Indian separation gel blood collection tube market. To achieve this ambitious goal, KriyaMed plans to increase its procurement of separation gel from our company on one hand, and on the other hand, invest heavily to enhance its own production capacity. She emphasized that establishing a deeper strategic alliance with our company, a source enterprise with strong technology and production capacity guarantee, is the core cornerstone to achieve this goal. In order to enable our esteemed partners to fully understand our strength and commitment, Mr. Wang Zhongxi, Chairman, and Ms. Wang Anqi, General Manager, personally accompanied Ms. Anu Moturi to visit and inspect our new factory located in Huanggang. On this trip, she not only saw the strong existing production capacity of your company, but also saw the huge development potential for the future. She highly appreciates our company's continuous investment in production capacity and technological upgrades, believing that this provides a solid and reliable guarantee for its future large-scale procurement needs, and is full of confidence in the stability and growth of our long-term cooperation. The successful visit of Ms. Anu Moturi marks a new and deeper stage in our partnership with KriyaMed after five years of testing. From stable suppliers to strategic partners working together, this transformation is based on deep mutual trust and a shared vision. We firmly believe that with Ms. Anu Moturi's outstanding leadership and clear market strategy, the strong alliance between the two parties will bear even more fruitful results. Hubei Xindesheng will spare no effort to support Kriya Medical Technologies in achieving its grand goal of becoming a market leader in India with competitive prices, stable product quality, and a reliable supply chain, and jointly create a mutually beneficial and win-win future!

In life science research, the pH stability of the experimental environment is a core factor affecting cell activity, enzyme catalytic efficiency, and protein structural integrity. As a classic buffer in the neutral to weakly alkaline range, 3- (N-morpholino) propanesulfonic acid (MOPS buffer) is widely used in fields such as cell culture, protein purification, and nucleic acid electrophoresis due to its excellent buffering capacity and biocompatibility. However, the concentration control of MOPS directly determines its buffering efficiency, and improper concentration may cause experimental deviation or even failure. 1, Dynamic balance between concentration and buffering capacity The buffering capacity of MOPS originates from the protonation deprotonation equilibrium between the sulfonic acid groups in its molecular structure and the morpholine ring. When the concentration of hydrogen ions in the solution changes, MOPS maintains pH stability by releasing or absorbing protons. Experiments have shown that the buffering capacity of MOPS is positively correlated with concentration within the range of 10-100 mM. For example, in protein ion exchange chromatography, a 10 mM MOPS buffer may result in a decrease in the separation between target proteins and impurity proteins due to insufficient buffer pairs; And 50 mM MOPS can achieve efficient separation of target proteins under specific elution conditions by precisely regulating the pH value of the mobile phase.But the higher the concentration, the better. When the concentration of MOPS exceeds 200 mM, the number of buffer pairs tends to saturate, and the effect of increasing concentration on pH stability significantly weakens. It may even interfere with the binding of proteins to chromatographic media due to high ion strength. In addition, high concentrations of MOPS may alter the fluidity of lipid membranes, affect the permeability of cell membranes, and thus interfere with the results of cell culture experiments. 2, Concentration sensitive window in cell culture Mammalian cells are extremely sensitive to the pH value of the culture medium, and MOPS, as a commonly used buffer component, should be strictly controlled at a concentration below 20 mM. Research has found that when the concentration of MOPS exceeds 20 mM, the thickness and barrier properties of the surface layer of rat endothelial cells change, resulting in a 15% -20% decrease in the efficiency of glucose uptake by cells. In addition, high concentrations of MOPS may interfere with the differentiation potential of embryonic stem cells by affecting calcium channel activity. 3, Practical points of concentration control Gradient testing method: For specific experimental systems, 5-10 MOPS concentration gradients (such as 5-100 mM) are pre designed, and the optimal concentration is determined by monitoring indicators such as pH stability, cell activity, or protein recovery rate. Compatibility verification: When using new chromatographic media or cell lines, it is necessary to verify the compatibility of MOPS concentration with the experimental system. For example, some metal chelation chromatography media may experience a decrease in performance due to the weak chelation of MOPS. Dynamic adjustment strategy: For long-term experiments (such as continuous cultivation or long-term electrophoresis), the effective concentration of MOPS can be maintained by adding buffer solution in stages to avoid pH loss due to buffer consumption. MOPS concentration control is a key link in the precision of life science experiments. By understanding the quantitative relationship between concentration, buffering capacity, and biological effects, and optimizing the buffering system based on specific experimental requirements, the reliability and reproducibility of experimental results can be significantly improved. In the future, with in-depth research on the interaction mechanism of MOPS molecules, concentration control strategies will become more refined, providing technical support for high-quality development in fields such as biopharmaceuticals and synthetic biology. Desheng is a professional manufacturer of biological buffering agents, established for more than ten years. It has rich experience in research and development, production, and product knowledge, and can provide customers with a large amount of technical support and after-sales guarantee. The biological buffer products currently produced include MOPS, TRIS, HEPES, TAPS, CAPS, BICINE, EPPS, PEP and a series of other biological buffer solutions. If you need them, please feel free to contact us at any time!      

In biochemical and molecular biology experiments, the stability of buffering agents directly affects the reliability of experimental results. PIPES, as a commonly used biological buffer, has attracted much attention for its chemical stability. The stability of PIPES buffer is particularly outstanding at room temperature and neutral pH environment. In a solid state, it can be stored for several years in a dry place at room temperature after sealing without significant degradation. When in solution state, within its effective buffering range, it can be stabilized for several weeks at 4 ℃ refrigeration and maintained for 1-2 weeks at room temperature. The degradation products are minimal, mainly trace amounts of piperazine derivatives. This provides convenience for experimental operations and reduces the hassle of frequently preparing buffer solutions. The temperature has a significant impact on the stability of PIPES. When heated for a short period of time at 60-80 ℃, its structure is basically stable and can meet the needs of some mild heating experiments. But do not perform high-pressure sterilization, as high temperature and pressure can cause slight decomposition, producing by-products such as piperazine and sulfonic acid. This not only reduces buffering capacity, but may also release trace amounts of harmful substances that affect biological samples, such as cells and enzymes. In terms of lighting, PIPES is relatively stable to ordinary indoor lighting, but long-term exposure to strong light (such as ultraviolet light) may result in slow degradation due to photooxidation. Therefore, the solution needs to be stored in a brown bottle away from light to delay the degradation process. PIPES exhibits good compatibility in interactions with chemical substances. It is relatively stable against common oxidants and not easily oxidized; Not sensitive to reducing agents and can coexist with sulfur-containing reducing agents, suitable for experiments that require a reducing environment, such as protein purification. More importantly, its coordination ability with most metal ions (such as Na ⁺, K ⁺, Ca ² ⁺, Mg ² ⁺) is weak, making it difficult to form stable complexes. This characteristic gives it a significant advantage in reaction systems containing metal ions (such as enzyme reactions and cell culture), and it will not interfere with experiments due to chelation of metal ions. This is a major highlight compared to buffering agents such as BICINE and HEPES. There are three main degradation pathways for PIPES: under strong acidic (pH12) conditions, the bond between the sulfonic acid group and the ethane group may break, releasing sulfonic acid groups and piperazine derivatives; When the temperature exceeds 100 ℃, the piperazine ring may partially open, producing amine and carboxylic acid by-products; Under UV irradiation, it may cause oxidation of the piperazine ring, resulting in the formation of imines or hydroxyl derivatives. Although degradation products are usually not highly toxic, they can reduce buffering capacity and extreme conditions should be avoided. In practical applications, controlling stability is crucial. The solution is recommended to be prepared and used immediately. If storage is required, it can be adjusted to pH 6.5-7.0, stored at 4 ℃ in the dark, and avoid repeated freezing and thawing. If aseptic treatment is required, 0.22 μ m filter membrane can be used for filtration. Meanwhile, PIPES can coexist with most salts, low concentration organic solvents (such as ethanol, DMSO), and biological reagents (enzymes, proteins) without worrying about stability conflicts. In summary, PIPES exhibits excellent chemical stability under conventional experimental conditions and is widely used in biological systems. As long as the storage and usage conditions are reasonably controlled, its buffering performance can be fully utilized, providing reliable guarantees for biological experiments. Since the establishment of Desheng, we have always adhered to the core values of "service first". For product after-sales, we have an elite after-sales team who not only meticulously track and follow up on customer feedback information, but also provide professional product technical guidance. In addition, we highly value every suggestion and opinion from our customers and actively adopt them to continuously optimize our services. Therefore, if you are looking for high-quality biological buffering agents, Desheng is undoubtedly your trusted choice, and we promise to do our best to meet your expectations.

The 92nd China International Medical Equipment Fair (CMEF) in 2025 will grandly kick off on September 26-29 at the China International Import and Export Fair in Guangzhou. As one of the most influential events in the global medical and health technology field, this year's CMEF is expected to gather thousands of enterprises from home and abroad to comprehensively showcase cutting-edge product technology and system solutions. Hubei Xindesheng Material Technology Co., Ltd. will showcase its full range of products at booth C06 in Hall 20.1, exploring the new future of diagnostic reagents with you! New Desheng's core product matrix launches a full-scale attack 1. High end biological buffer series Xindesheng has a complete range of biological buffer products, covering dozens of commonly used and customized types such as TRIS, HEPES, MOPS, etc., with a daily production capacity of up to 5 tons. The product has high purity and stable process, and can be widely used in fields such as molecular diagnosis, immune detection, cell culture, etc. It maintains the pH value of the reaction system and provides a solid guarantee for the reliability of experimental results. 2. IVD Diagnostic Core Raw Material Series Chromogenic substrate: It has high water solubility, high sensitivity, color stability, and wide system adaptability, supporting multiple color source selections and detection scenarios, significantly improving detection sensitivity and stability. Luminescent reagents: including luminol, isoluminol, and various functional acridine ester products, with high luminescence efficiency and fast reaction speed, meeting the diverse needs of chemiluminescence immunoassay. Enzyme preparations: covering high value-added projects such as cardiovascular, infectious disease, and tumor marker detection, with characteristics of high activity and high purity. 3. Blood collection reagent series As one of the earliest domestic enterprises to produce a complete set of blood collection tube additives, Xindesheng provides stable quality and complete product categories of blood collection tube reagents with mature technology and rich experience, and can also provide deep customization services to fully meet customers' personalized needs. Xin Desheng: Deeply cultivated for 20 years, trustworthy Hubei Xindesheng Material Technology Co., Ltd. was established in 2005. It is a national high-tech enterprise specializing in the research, development, production, and sales of blood test pre-processing reagents, in vitro diagnostic reagent raw materials, and biological buffering agents. The company adheres to the concept of "quality first, customer-oriented" and can provide professional customized development and large-scale production services. At present, Desheng is actively preparing for the construction of the new Huanggang factory. As of now, the main structure of Warehouse 3 has been successfully capped, and the construction of the gutter and roof system of Production Building 1 is proceeding efficiently. The new factory is committed to building a domestic base for high-end biological buffering agents, and the upgrading of production capacity is just around the corner. This will further consolidate Xindesheng's supply chain advantages and market competitiveness in the field of IVD raw materials. In person interaction, enjoy multiple benefits and values During the exhibition, Xindesheng sincerely invites you to visit booth C06 in Hall 20.1, participate in on-site interaction, and experience more exclusive benefits and opportunities for in-depth communication: 1. We not only provide you with a comfortable and cozy resting area and a variety of drinks and tea breaks, but also offer face-to-face communication with technical and marketing teams to obtain the latest product information and technical solutions, bringing new ideas and cooperation opportunities for your current project. 2. By visiting the booth for interaction, you can receive exquisite and practical gifts for free (including product samples, customized canvas bags, multifunctional USB drives, etc.). Each gift is designed to provide convenience for your daily research and development and work. 3. On site participation and interaction can also give priority to understanding the latest production line planning and customer exclusive support of Xindesheng, obtain more market trend interpretation and product customization resources, help reduce costs and increase efficiency, and seize market opportunities. Meet in Guangzhou and discuss the future together From September 26th to 29th, Hubei Xindesheng is looking forward to your visit at the C06 booth in Hall 20.1 of the China Import and Export Fair Complex (Pazhou Complex) in Guangzhou! We look forward to face-to-face communication with you on industry trends, sharing innovative achievements, and working together to promote the localization process of diagnostic reagent raw materials, creating new opportunities for cooperation. We are waiting for you in Guangzhou. See you soon!

Fluttering banners, embarking on a new journey, fighting fiercely for a hundred days to see the true chapter In the summer of 2025, on the hot land of innovation and entrepreneurship in Huanggang, Hubei, a modern chemical plant representing a new height in the industry is rising at an astonishing speed. Since the foundation laying and departure on July 18th, the Huanggang new factory project of Hubei Xindesheng Material Technology Co., Ltd. has embarked on a construction journey of racing against time with the spirit of "time waits for no one, seize the day and night". In just two months, the project team has written an impressive report card with wisdom and sweat, perfectly interpreting the profound connotation of "Desheng efficiency" with tangible construction results, injecting a shot in the arm for local economic development. Warehouse sealing: Warehouse center takes shape first On September 14, 2025, the project construction once again reached a milestone moment - the main structure of Warehouse 3 successfully completed the topping out work! This advanced design and fully functional storage facility has completed the main construction first, which means that the construction of the new factory has achieved significant results in this stage. The topping out of the warehouse not only creates conditions for subsequent internal decoration and equipment installation, but also ensures the efficient operation of the future factory logistics and warehousing system. At the topping out ceremony, the project leader stated, "The rapid topping out of Warehouse 3 is a testament to our careful organization and scientific construction, and also a good start for the on-time delivery of the entire project. Multi line joint promotion: Comprehensive construction momentum is unstoppable At the same time, the construction of other key nodes in the new factory area is also progressing efficiently and synchronously, presenting a busy scene of multiple blooming points and simultaneous progress. The construction of the gutter and roof system in the 1 # production plant is in full swing, creating favorable conditions for the installation of internal equipment in the plant; The circulating water tank supporting the factory area has completed the base treatment and entered the plastering construction stage, and the bottom plate formwork construction of the base water tank and the initial rainwater tank has also been fully carried out. The synchronous construction of these supporting facilities ensures the coordinated operation of production and environmental protection systems in the future factory area, reflecting New Desheng's high emphasis on sustainable development. Strategic positioning: Building a domestic base for high-end biological buffering agents The Huanggang New Factory project is committed to building a domestic high-end biological buffer production base, focusing on breakthroughs in key preparation technologies for a series of high-end biological buffers such as TRIS, HEPES, MOPS, etc. By constructing multiple intelligent production lines, the project will achieve a significant increase in the production of high-end biological buffering agents after it is put into operation, and it is expected that the annual output value will achieve a leapfrog growth. The construction of this base will effectively break the technological and market monopoly of foreign manufacturers in the field of high-end biological buffering agents. Anchor new goals and embark on a new journey The rapid progress of Huanggang's new factory construction is not only an important milestone in the development history of Xindesheng, but also a microcosm of China's intelligent manufacturing speed. From a blueprint to the initial scale of the factory building, from the groundbreaking ceremony to the topping out of the warehouse, the early completion of every milestone embodies the wisdom and sweat of all builders, demonstrating the corporate spirit of "pioneering innovation and pursuing excellence" of Xindesheng people. With the continuous advancement of the project, it will undoubtedly inject strong impetus into the future development of Xindesheng and contribute important strength to the high-quality development of the local economy.

For a long time, some studies have assumed that Bicine cannot interact with metal ions. However, an increasing number of facts indicate that Bicine can form stable binary or ternary complexes with metal ions, exhibiting certain chelating properties. The molecular structure of Bicine buffer is similar to that of glycine. This structure reduces the hydrolysis ability of the amino end, enhances overall stability, and also creates conditions for its binding with metal ions. Research has shown that Bicine can chelate with heavy metal ions such as copper (Cu), cadmium (Cd), and lead (Pb). However, this chelation effect is relatively weak and does not significantly interfere with the normal function of metal ions in most biochemical reactions, especially enzymatic reactions. In enzymatic reactions, metal ions often act as cofactors or coenzymes in the catalytic process, and their activity is highly influenced by various factors, with pH being one of the key factors. Extreme pH values can alter the binding state between metal ions and enzymes, thereby affecting catalytic activity. Bicine maintains pH stability in the solution while having weak chelation effect on metal ions, making it an ideal choice for enzymatic reactions that require the retention of metal ion activity. For example, in the serum guanine enzyme assay, the presence of Bicine can provide a stable pH environment for enzymatic reactions, and due to its weak binding properties with metal ions, it will not interfere with the role of metal ions in the reaction, ensuring the accuracy of the measurement results. From an application perspective, this characteristic of Bicine enables it to be widely used in many fields. In protein crystallization solution, Bicine can maintain the pH stability of the system without affecting the necessary interactions between proteins and metal ions due to excessive chelation of metal ions, which is beneficial for the growth and stability of protein crystals. Bicine acts as a buffer when extracting enzymes from various plant species, ensuring a suitable pH environment and maintaining metal ions in a free state that can participate in the composition of enzyme active centers or promote enzyme activity. In polymerase chain reaction (PCR), Bicine buffer system provides stable acid-base conditions for the reaction, while not hindering the reaction due to strong chelation of metal ions (such as magnesium ions, activators of Taq DNA polymerase in PCR reaction). Overall, the weak binding properties of the biological buffer Bicine with metal ions have more advantages than disadvantages in most biochemical and molecular biology applications. It provides a stable and suitable environment for numerous biochemical reactions that require the participation of metal ions, ensuring the authenticity and reliability of experimental results. With the continuous deepening of research and the expansion of application fields, fully understanding and reasonably utilizing the characteristics of Bicine and metal ions will inject new vitality into the development of related fields. The Bicine buffer produced by Hubei Xindesheng Material Technology Co., Ltd. has a low chloride ion content and all indicators meet relevant standards. In addition to Bicine buffer, Desheng actively researches and develops dozens of biological buffers such as TRIS and Hepes commonly used in the market. If you are interested, please click on the Desheng official website to learn more details! Overall, the weak binding properties of the biological buffer Bicine with metal ions have more advantages than disadvantages in most biochemical and molecular biology applications. It provides a stable and suitable environment for numerous biochemical reactions that require the participation of metal ions, ensuring the authenticity and reliability of experimental results. With the continuous deepening of research and the expansion of application fields, fully understanding and reasonably utilizing the characteristics of Bicine and metal ions will inject new vitality into the development of related fields. The Bicine buffer produced by Hubei Xindesheng Material Technology Co., Ltd. has a low chloride ion content and all indicators meet relevant standards. In addition to Bicine buffer, Desheng actively researches and develops dozens of biological buffers such as TRIS and Hepes commonly used in the market. If you are interested, please click on the Desheng official website to learn more details!  

現在、中国のプライマリヘルスケアシステムは前例のない変革とアップグレードを経験しており、体外診断薬（IVD）分野で爆発的な成長を遂げています。この傾向は、最近の「南広東での百万人の才能集結」医療・健康就職フェアで確認されました。334の雇用主が6500以上の求人を提供し、特に郡レベルの医療機関における画像診断、麻酔などの分野の専門家に対する需要が顕著でした。これらの部門の発展はIVD技術と密接に関連しており、プライマリヘルスケアにおける診断検査に対する強い需要を反映していることは注目に値します。 需要急増の背後にある深い原動力 政策配当の持続的な放出が主な原動力です。国家政策の支援により、草の根医療機関のハードウェア設備が包括的にアップグレードされ、現代的な診断および治療機器が郷鎮保健センターや村の診療所に設置されました。ハードウェアの改善は、多様な検査プロジェクトを実施するための条件を作り出し、同時に、草の根医師の間での正確な診断に対する需要も急増しました。POCTに代表される迅速検出技術は、草の根レベルでのタイムリー性と正確性の両方の追求を正確に満たすことができます。 人口動態の変化が新たな課題をもたらします。世界的なデータによると、侵襲性真菌症の発生率は年率0.9％で増加しており、高齢者、特に慢性疾患を抱える人々が脆弱になっています。このような疾患の草の根レベルでの早期特定は、真菌培養やG検査などのIVD技術に大きく依存しており、プライマリヘルスケア機関が診断能力を強化する必要があります。 階層的な診断と治療システムの深化が医療のパターンを再構築します。草の根レベルでの最初の診断という政策の推進により、草の根医療機関はより包括的な診断システムを確立する必要があります。迅速で信頼性の高いIVD検査は、医師が病状をタイムリーに評価するのに役立つだけでなく、患者の紹介のための科学的根拠を提供し、医療資源の利用効率を効果的に向上させます。 需要急増の背後にある深い原動力 政策配当の持続的な放出が主な原動力です。国家政策の支援により、草の根医療機関のハードウェア設備が包括的にアップグレードされ、現代的な診断および治療機器が郷鎮保健センターや村の診療所に設置されました。ハードウェアの改善は、多様な検査プロジェクトを実施するための条件を作り出し、同時に、草の根医師の間での正確な診断に対する需要も急増しました。POCTに代表される迅速検出技術は、草の根レベルでのタイムリー性と正確性の両方の追求を正確に満たすことができます。 人口動態の変化が新たな課題をもたらします。世界的なデータによると、侵襲性真菌症の発生率は年率0.9％で増加しており、高齢者、特に慢性疾患を抱える人々が脆弱になっています。このような疾患の草の根レベルでの早期特定は、真菌培養やG検査などのIVD技術に大きく依存しており、プライマリヘルスケア機関が診断能力を強化する必要があります。 階層的な診断と治療システムの深化が医療のパターンを再構築します。草の根レベルでの最初の診断という政策の推進により、草の根医療機関はより包括的な診断システムを確立する必要があります。迅速で信頼性の高いIVD検査は、医師が病状をタイムリーに評価するのに役立つだけでなく、患者の紹介のための科学的根拠を提供し、医療資源の利用効率を効果的に向上させます。 将来の見通し 人材不足や品質管理などの課題にもかかわらず、草の根IVD市場は、政策支援と技術進歩によって大きな潜在力を秘めています。今後数年間で、遠隔医療や人工知能などの新技術の統合と応用により、草の根診断サービスは、よりインテリジェントで正確な方向へと発展し、健康な中国の建設を強力に支援することが期待されています。 長年の開発の後、湖北新德生材料技術は革新的なコンセプトを堅持し、製品品質とサービスレベルを継続的に向上させ、IVD産業の発展に貢献します。  

アクリジンエステルは,化学発光反応剤免疫検査,ヌクレイン酸検知,バイオセンサーなどの分野で広く使用されています.高感度,急速な発光,低背景干渉により,その独特の化学的特性により,溶解過程で特定の仕様を厳格に遵守する必要があります.反応剤の無効化や実験の失敗につながる可能性があります.この記事では,アクリジンエステルの保存特性から始まり,それらの科学的溶解方法と操作ポイントを体系的に分析します.. アクリジンエステルの保存特性:冷凍乾燥粉末の必要性および低温照明の回避 アクリジンエステルは,通常冷凍乾燥粉末の形で提供され,水解反応を抑制し,水分を除去することによって試料の安定性を延長するように設計されています.凍結 乾燥 プロセス は,水分 の 95% 以上 を 取り除く こと が でき ますアクリジンエステル分子を不活性状態に保ち,水分による結合や分解を避ける.低温 (通常は -20 °C以下) と光の回避条件は,アクリジンエステルの保存の鍵である.低温では分子熱運動を遅らせ,水解速度を低下させ,光を避けると光敏感反応による構造損傷を防ぐことができます.NHS (N-ヒドロキシスクシニミド) グループを含むアクリジンエステルは,光と水分の両方に非常に敏感である.室温や光に何時間も曝されれば 50%以上の活動量が減少します 溶媒の選択: プロトン化されていない溶媒の必要性 アクリジンエステルの溶解は,独特の化学構造に基づいて水溶液を避ける必要があります.アクリジンエステル分子におけるエステル結合とNHSグループは,水分分子との核好性攻撃反応に非常に敏感である.特にNHSグループを含むアクリジンエステルでは,水中での水解半減期は数分から数時間です.しかし,プロトン化されていない溶剤で数日,あるいは数週間まで延長することができます.したがって,次の2種類の溶媒を使用してアクリジンエステルを溶解する必要があります. 1.極性非プロトン溶媒:ジメチル硫酸化物 (DMSO) とN,N-ジメチルフォーマミド (DMF) など分子に活性水素がないため,水解反応に参加するための陽子を供給できないDMSOは,低毒性により,研究室で最も一般的に使用されている選択肢となっています.高沸点 (189 °C)DMFは,より強い溶解性があるため,高濃度のアクリジンエステルの調製に適しています. 2.混合溶剤システム: 極度に溶けないアクリジンエステル誘導体についてはDMSOとアセトニトリル (ACN) やダイメチルセタミド (DMA) の混合溶媒が極度を調整することで溶解を促進することができる.例えば,DMSOとACNを7:3の体積比で混ぜると,溶液の粘度が低下し,プロトン化されていない性質が保たれ,後の操作が容易になります. 適用シナリオの調整: ラベル付け反応から発光検出 溶けたアクリジンエステル溶液は,タンパク質,抗体,または核酸の化学発光ラベルに直接使用することができます.例えば,免疫検査では,アクリジンエステル抗体結合物は水性バッファ内の抗原に結合し,その後,過酸化水素と過酸化ナトリウムを加えることで化学発光反応を引き起こすことができる.アクリジンエステルの発光効率に影響を及ぼすのを避けるために,ラベル付け反応は,pH (通常7.2-7.6) と離子強度を厳格に制御する必要があります. 結論 アクリジンエステルの溶解は,安定した貯蔵と効率的な適用を結びつける重要なリンクです. プロトン化されていない溶媒を選択し,操作手順を標準化することで,応用シナリオに適応するアクリジンエステルの化学発光の可能性が完全に解放され,生物学的検出のための非常に敏感で特異的なソリューションを提供します.新しい抗水解アクリジンエステル誘導物の開発化学発光技術における進歩をさらに促進する. 製造者として発光反応剤,デシェンは現在,高品質のアクリジンエステル粉末の供給に完全にコミットしています.これらの製品は,使用に便利であるだけでなく,その発光感性にも知られています.非常に短い期間で正確で信頼性の高い実験結果を得られるようにします購入の必要性がある場合,または詳細を学びたい場合は,相談のために私たちの公式ウェブサイトをクリックしてください.  

フリー脂肪酸 (FFA) は 人間のエネルギー代謝の主要な中間産物であり,その異常レベルは糖尿病,肥満,心血管疾患,代謝症候群と密接に関連しています.FFA濃度を正確かつ迅速に測定することは 臨床診断の重要な指標であるだけでなく多くの検出方法のうち,色素測定基板は,トップス酵素光測定法は,高い感度,強い安定性,便利な操作により,FFAの決定のための主流技術になりました. 技術原理: 酵素反応と色測定反応の完璧な組み合わせ TOPS酵素光測定の核は,FFAの酵素酸化プロセスを色素測定反応と結びつけ,色素測定方法によって定量的に分析することです.具体的には,検出プロセスは2段階に分かれます: 1酵素酸化段階:サンプル内のFFAは,アセチルCOA合成によって催化され,アセチルCOAを生成するためにATPとCOAと結合し,ピロフォスファートが放出されます.アセチルCOA酸化酶はさらにアセチルCOAを酸化して過酸化水素 (H2O2) を生成する.. 2染色反応段階: ペロキシダース (HRP) の催化によりH2O2は,色素基質TOPSと4アミノアンチピリン (4-AAP) とレドックス反応を受け,安定した赤いキノンイミン化合物を生成する.化合物の色深さは,FFAの濃度と線形的に関係しています.FFA含有量は,スペクトロフォトメーターで吸収量を測定することによって正確に計算できる (通常は波長550-570nm). 技術上の利点: 敏感で安定し,操作が簡単 伝統的な方法と比較して,TOPS酵素光測定には重要な利点があります. 1高い感度:TOPSは,伝統的な色剤 (銅剤など) よりもはるかに高いモラー吸収性を有し,FFAをμmol/Lまで検出することができる.血清などの低濃度サンプルを正確に分析するのに特に適しています.. 2強い安定性:TOPSは安定した化学特性を持ち,温度,pH変動,またはサンプルマトリックス干渉に容易には影響を受けません.検出結果の可複性と信頼性を確保するさらに,キット形式 (二重反応体システム) は,操作プロセスをさらに簡素化し,人間のエラーを減らす. 3. 便利な操作:複雑な事前処理段階 (有機抽出や派生など) が不要です.サンプルを直接混合し,試料とインキュバートすることができます.そして検出は10〜15分で完了することができます検出時間を大幅に短縮します 4高コスト効率: ガス染色体学や液体染色体学と比較して,TOPS酵素光測定には高価な機器や機器が不要で,反応剤消費量が少ない.臨床実験室で広範囲に広めるのに適しています. 臨床 応用: 病気 の 診断 から 健康 管理 まで TOPS酵素光測定の応用シナリオは広く,臨床診断,代謝研究,薬の開発などの複数の分野をカバーしています 1心血管疾患リスク評価: FFA の値の上昇は動脈硬化症と心筋 ischemia の独立したリスク因子です.定期 的 に 検診 する こと は,早期 の 診断 と 予後 診断 の 監視 に 役立つ. 2代謝疾患の管理: 糖尿病患者はしばしばFFA代謝障害に伴います.FFA の 濃度 を 動的 に 監視 する こと に よっ て,インスリン 治療 プログラム を 最適化 し,血糖 の 変動 を 制御 する こと が でき ます. 結論:TOPS酵素光測定法は,革新的な科学原理と実用的な技術的実施に基づい,FFAの検出に効率的で正確な解決策を提供します.臨床診断から健康管理へ基礎研究から薬の開発まで この技術は 代謝医学の進歩を 継続的に推進し 人間の健康を守っています トップス・センターなど新しいトリンダーの試料Hubei Xindesheng Material Technology Co. Ltd.によって生産されているものは高純度,水溶性,安定した生産プロセス,少量差があります.すべての指標は関連基準を満たしている近い将来,購入の必要性がある場合は,私に連絡してください. または詳細については公式ウェブサイトをクリックしてください!  

生物学や生化学実験では生物学的バッファ剤溶液のpH安定性を維持するためのコア反応体として機能し,その不妊処理は実験結果の正確性と信頼性に直接影響します.細胞培養からタンパク質浄化へ実験型,反応剤の特性に基づいて,バッファ溶液の滅菌決定を包括的に判断する必要があります.運営基準. 滅菌の必要性:実験の種類がリスクレベルを決定する 1高感度実験に対する厳格な要求 細胞培養や遺伝子編集や単一分子検査などの実験では 高度の不妊性が必要ですが 微生物汚染は 細胞死,異常な遺伝子発現,信号の干渉例えば,MOPSバッファはRNA電解に一般的に使用されているが,そのpH安定性は微生物代謝物によって容易に影響を受ける.実験に希少なサンプルや長期栽培が含まれる場合高圧滅菌は,汚染源を効果的に排除できます. 同様に,高圧滅菌後,BES バッファ溶液の pH 安定性が著しく改善されるイオン強さに敏感な細胞実験に適している. 2長期保存の安定性保証 貯蔵中に微生物を繁殖させ,pHの変動や降水を引き起こす可能性があります.リン酸塩を含むバッファ溶液は,高温でカルシウムとマグネシウムイオンと溶けない複合体を形成する傾向があります.長期保存を必要とする Tris HCl バッファル溶液では高温・高圧消毒で 化学的安定性を保ち 微生物の成長による活性成分の分解を 防ぐことができます. 3外部からのタンパク質の干渉を避ける 微生物自身に含まれるタンパク質は 交差反応によって実験結果に干渉する可能性があります ウェスタン・ブロット実験では バッファが無菌化されていない場合バクテリアタンパク質は標的タンパク質に非特異的な結合を経験する可能性がありますステリライゼーション治療は,そのような干渉源を完全に除去することができます.特に低濃度タンパク質検出や高特異性抗体発酵シナリオに適しています. 滅菌 に 関する 実用 的 な 考慮: 費用 と 利益 の 均衡 1実験コストと運用の複雑さ 高圧滅菌には 専門機器が必要で 長い時間かかりますが 膜過濾は 迅速ですが 定期的に膜を 交換する必要があります膜フィルタリングは消耗品のコストを増やす可能性があります■小規模または高価な実験では,無菌保証の利点はコストをはるかに上回ります.例えば,遺伝子療法ベクトルの生産では,消毒バッファの使用は,バッチ汚染リスクを回避し,製品の安全性を保証することができます.. 2運営基準の補完的な役割 実験中,スチロール操作手順は,スチロールされた場合でも,続けなければなりません.例えば,移植プロセス中に無菌なパイペットの先端を使用し,超清潔な作業台で動作すると汚染のリスクがさらに減少しますさらに,実験者 が 研究室 の コート,手袋,メガネ を 履い て いる と,人間 の 微生物 に よっ て バッファー 溶液 の 二次 的 汚染 を 避け ます. 結論: 科学的決定と精密な不妊 生物学的バッファング剤の不妊処理は,一型一型のアプローチではなく,実験の種類,反応剤の特性,運用条件滅菌は,高感度実験,長期保存,または外部のタンパク質干渉を含むシナリオにおける結果の信頼性を確保するための必要な手段である.常用実験や熱感性のあるバッファ剤用膜フィルタリングや厳格な無毒操作は高圧滅菌に取って代わることができます. 科学的に滅菌方法を選択し,操作手順を標準化することで,生物学的バッファング剤の性能を最大化できる生物学的研究に堅実な支援を提供しています Hubei Xindesheng Material Technology Co., Ltdは,材料の製造業者である診断用試料Tris,Tris HCl,Bis Tris,Bicine,TAPSなど様々な生物学的バッファング剤を供給できる原材料です.いつでも連絡してください.!  

2025年9月3日の朝 湖北新興材料技術株式会社 (株) は 9月3日の軍事パレードのライブ放送を 従業員全員に国の壮大な力を目撃し 時代の精神を共に感じますこの活動は,愛国教育を深め,チーム凝結を強化し,従業員の国民的誇りと専門的な使命感を刺激することを目的としています.   午前9時,会社の会議室は 厳粛で熱心な雰囲気でいっぱいでしたすべての従業員は,会社によって発行された明るい赤い旗を握り,集中した表情で大きなスクリーンでパレードを見ています壮大な軍隊が 断固とした歩みで進み 武器や装備が一つずつ現れ 青い空に飛ぶ戦闘機が 壮大な道筋を描いた時真面目な賞賛と暖かい拍手が 繰り返し 現場から噴出しました従業員たちは赤い旗を振り回し祖国の国防建設における日益強固な総合的な国家力と輝かしい成果を心から誇りに感じて光栄に思います.   王正希委員長は演説の中で 軍参戦を見ながら得た深い啓蒙について 熱心に語りました熱い暑さの中で数時間 じっと立っていた兵士たちの 果敢な姿は この時代の貴重な職人精神を反映しているこの忍耐力には 個人の価値観を国の運命に 組み込むという崇高な選択がありますシンデシュン市民も祖国を大切にして 企業と国の発展と 個人的な成長を密接に結びつけるべきです王氏はまた,壮大な軍事パレードが国の繁栄と安定を示した,と指摘しました.企業が安心して運営し 継続的に発展するための 堅牢な基盤ですニューデシェンは 国の全体的な発展に 独自の発展を統合し 時代がもたらした機会を 実用的な行動で報じなければなりません   Chairman Wang Zhongxi called on all employees of Xindesheng to transform the surging enthusiasm and deep patriotism inspired by watching the military parade into practical actions that are down-to-earth軍団パレードの精神を 深く学び 理解するよう求めます 忍耐と忠誠 協力と責任を体現します研究開発プロジェクトに注入します生産プロセスや市場でのあらゆるサービスにおいて より活発な戦いの精神と 卓越性への追求の態度をもって我々は,IVDの分野における革新と突破にコミットしています卓越した仕事成果と 企業業績の向上地域経済の繁栄と産業の技術的進歩に貢献しますこの野心的な使命を 偉大な母国への 誠実で感動的な贈り物に変えましょう   現在,湖北新興は急速な発展の新たな段階にあります. 黄冈の新しい生産基地の建設は加速段階に入りました.高級製品の生産基盤を確立することを目的としています生物学的バッファ剤中国では,輸入依存をなくし,主要原材料を国内で代用する. We firmly believe that Hubei Xindesheng will transform the pride and sense of mission inspired by the military parade into an inexhaustible driving force for promoting the independent and controllable development of the IVD industry chain with high quality高品質の革新的な製品と 卓越した産業貢献により